Neuropathology Unit, Division of Brain Sciences, Department of Medicine, Imperial College London, Charing Cross Campus, St Dunstan's Road, London, UK.
Acta Neuropathol Commun. 2014 Feb 14;2:21. doi: 10.1186/2051-5960-2-21.
Microglial activation is a pathological feature common to both Alzheimer's and Parkinson's diseases (AD and PD). The classical activation involves release of pro-inflammatory cytokines and reactive oxygen species. This is necessary for maintenance of tissue homeostasis and host defense, but can cause bystander damage when the activation is sustained and uncontrolled. In recent years the heterogeneous nature of microglial activation states in neurodegenerative diseases has become clear and the focus has shifted to alternative activation states that promote tissue maintenance and repair. We studied the distribution of CD163, a membrane-bound scavenger receptor found on perivascular macrophages. CD163 has an immunoregulatory function, and has been found in the parenchyma in other inflammatory diseases e.g. HIV-encephalitis and multiple sclerosis. In this study, we used immunohistochemistry to compare CD163 immunoreactivity in 31 AD cases, 27 PD cases, and 16 control cases. Associations of microglia with pathological hallmarks of AD and PD were investigated using double immunofluorescence.
Parenchymal microglia were found to be immunoreactive for CD163 in all of the AD cases, and to a lesser extent in PD cases. There was prominent staining of CD163 immunoreactive microglia in the frontal and occipital cortices of AD cases, and in the brainstem of PD cases. Many of them were associated with Aß plaques in both diseases, and double staining with CD68 demonstrates their phagocytic capability. Leakage of fibrinogen was observed around compromised blood vessels, raising the possibility these microglia might have originated from the periphery.
Increase in microglia's CD163 immunoreactivity was more significant in AD than PD, and association of CD163 immunoreactive microglia with Aβ plaques indicate microglia's attraction towards extracellular protein pathology, i.e. extracellular aggregates of Aβ as compared to intracellular Lewy Bodies in PD. Double staining with CD163 and CD68 might point towards their natural inclination to phagocytose plaques. Fibrinogen leakage and compromise of the blood brain barrier raise the possibility that these are not resident microglia, but systemic macrophages infiltrating the brain.
小胶质细胞激活是阿尔茨海默病(AD)和帕金森病(PD)的共同病理特征。经典激活涉及促炎细胞因子和活性氧的释放。这对于维持组织内稳态和宿主防御是必要的,但当激活持续且不受控制时,会导致旁观者损伤。近年来,神经退行性疾病中小胶质细胞激活状态的异质性变得明显,人们的关注点已经转移到促进组织维持和修复的替代激活状态。我们研究了 CD163 的分布,CD163 是一种存在于血管周围巨噬细胞上的膜结合吞噬受体。CD163 具有免疫调节功能,并且在其他炎症性疾病(如 HIV 性脑炎和多发性硬化症)的实质中也有发现。在这项研究中,我们使用免疫组织化学比较了 31 例 AD 病例、27 例 PD 病例和 16 例对照病例中的 CD163 免疫反应性。使用双重免疫荧光研究了小胶质细胞与 AD 和 PD 的病理标志物的关联。
所有 AD 病例的实质小胶质细胞均对 CD163 呈免疫反应性,而 PD 病例的反应性较弱。AD 病例的额皮质和枕皮质以及 PD 病例的脑干中可见 CD163 免疫反应性小胶质细胞的明显染色。在两种疾病中,它们中的许多都与 Aβ斑块有关,并且与 CD68 的双重染色表明它们具有吞噬能力。在受损血管周围观察到纤维蛋白原渗漏,这表明这些小胶质细胞可能来自外周。
AD 中小胶质细胞 CD163 免疫反应性的增加比 PD 更为显著,与 CD163 免疫反应性小胶质细胞与 Aβ斑块的关联表明,小胶质细胞对细胞外蛋白病理学的吸引力,即与 PD 中的细胞内路易体相比,对 Aβ的细胞外聚集物的吸引力。CD163 和 CD68 的双重染色可能表明它们自然倾向于吞噬斑块。纤维蛋白原渗漏和血脑屏障受损表明这些不是常驻小胶质细胞,而是浸润大脑的系统性巨噬细胞。